1. Decreased antioxidant capacity and CPT1A pattern expression*
2. Promotion of CYP1B1, which is involved in the bioactivation of procarcinogens 3. Induction of liver cancer in rodents**4. Promotion of self-renewal ability and sphere-formation rate of cancer stem cells (CSCs) 5. Suppression on the proliferation and vitality, and the induction of apoptosis of T cells*. The gene discussed is CPT1A; the disease is liver cancer.